NEUARTIGE PYRIDAZINE

European patent · EP3873472 · In force

Register entry

Publication number
EP3873472
Application number
EP19801229
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Oct 25, 2019
Published
Sep 8, 2021
Granted
Jul 12, 2023
Protection ends at the latest
Oct 24, 2039
Next annual fee due
Oct 31, 2026
IPC classes
A61K 31/501 (2006.01)
A61P 29/00 (2006.01)
C07D 237/02 (2006.01)
C07D 237/22 (2006.01)
C07D 401/12 (2006.01)
Priority
EP 18203226 29.10.2018
PCT application
PCT/EP2019/079231 25.10.2019
PCT publication
WO2020/089098 07.05.2020
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 1, 2025

    Change

    Published in Swissreg on 01.11.2025

  2. Nov 1, 2024

    Change

    Published in Swissreg on 01.11.2024

  3. May 22, 2024

    Change

    Published in Swissreg on 22.05.2024

  4. Nov 1, 2023

    Change

    Published in Swissreg on 01.11.2023

  5. Jul 12, 2023

    Granted

    Published in Swissreg on 12.07.2023

Parties

Holder

Boehringer Ingelheim International GmbH

Binger Strasse 173, 55216 Ingelheim am Rhein, DE

Inventor

BRETSCHNEIDER, Tom

55216 INGELHEIM AM RHEIN, DE

KUTTRUFF, Christian Andreas

55216 INGELHEIM AM RHEIN, DE

ROTH, Gerald Juergen

55216 INGELHEIM AM RHEIN, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.